Investing.com - Immunitybio Inc (NASDAQ: IBRX) reported third quarter EPS of $-0.14, $0.04 better than the analyst estimate of $-0.18. Revenue for the quarter came in at $6.1M versus the consensus estimate of $2.93M.
Immunitybio Inc's stock price closed at $4.95. It is up 23.44% in the last 3 months and up 43.90% in the last 12 months.
Immunitybio Inc saw positive EPS revisions and negative EPS revisions in the last 90 days. See Immunitybio Inc's stock price’s past reactions to earnings here.
According to InvestingPro, Immunitybio Inc's Financial Health score is "weak performance".
Check out Immunitybio Inc's recent earnings performance, and Immunitybio Inc's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar